IP Verse

Perfusion Bioreactor And Related Methods Of Use

Patent No. EP3697887 (titled "Perfusion Bioreactor And Related Methods Of Use") was filed by Regeneron Pharmaceuticals on Oct 15, 2018. The application was issued on Apr 6, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBJan 9, 2023SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB
SARTORIUS STEDIM BIOTECHDec 21, 2022MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3697887

REGENERON PHARMACEUTICALS
Application Number
EP18797333A
Filing Date
Oct 15, 2018
Status
Revoked
Sep 6, 2024
Publication Date
Apr 6, 2022
External Links
Slate, Register , Google Patents